Investors Business Daily
07 Oct 2025, 13:51 UTC · 50w ago
How Arcus Biosciences Aims To Take On Merck In Cancer Treatment
Verdict
Headline takes no side. We score SMMT −1.00 — strongly bearish.
- Expected · SMMT
−1.00strongly bearish
−1 bearish0bullish +1More negative than 95% of ticker scores this week
- Actual


